Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Murphy

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|February 22, 2001
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373R M Gulick, L M Smeaton, R T D'Aquila, et al.
AIDS (London, England)|February 24, 2001
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week resultsR L Murphy, S Brun, C Hicks, et al.
The Journal of Infectious Diseases|March 9, 1999
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study TeamR L Murphy, R M Gulick, V DeGruttola, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 2001
Skin test reactivity and cellular immune responses to Mycobacterium avium sensitin in AIDS patients at risk for disseminated M. avium infectionC F von Reyn, P L Williams, H M Lederman, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 17, 2019
Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in MaliM Sylla, O Dolo, A I Maiga, et al.
The New England Journal of Medicine|December 24, 1998
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials GroupW M El-Sadr, R L Murphy, T M Yurik, et al.
Annals of Internal Medicine|October 3, 2000
Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study TeamJ S Currier, P L Williams, S L Koletar, et al.
Journal of Blood & Lymph|February 10, 2018
Establishing Reference Ranges of Hematological Parameters from Malian Healthy AdultsB Kone, M Maiga, B Baya, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|February 22, 2001
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373R M Gulick, L M Smeaton, R T D'Aquila, et al.
AIDS (London, England)|February 24, 2001
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week resultsR L Murphy, S Brun, C Hicks, et al.
The Journal of Infectious Diseases|March 9, 1999
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study TeamR L Murphy, R M Gulick, V DeGruttola, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 2001
Skin test reactivity and cellular immune responses to Mycobacterium avium sensitin in AIDS patients at risk for disseminated M. avium infectionC F von Reyn, P L Williams, H M Lederman, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 17, 2019
Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in MaliM Sylla, O Dolo, A I Maiga, et al.
The New England Journal of Medicine|December 24, 1998
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials GroupW M El-Sadr, R L Murphy, T M Yurik, et al.
Annals of Internal Medicine|October 3, 2000
Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study TeamJ S Currier, P L Williams, S L Koletar, et al.
Journal of Blood & Lymph|February 10, 2018
Establishing Reference Ranges of Hematological Parameters from Malian Healthy AdultsB Kone, M Maiga, B Baya, et al.
Pageof 11